Nordic Capital is to acquires a majority share in IntegriChain, a provider of pharmaceutical technology, data, consulting, and outsourcing solutions designed to improve how life sciences products reach customers.
IntegriChain delivers ICyte, a fully integrated platform for commercialisation and market access, helping manufacturers bring their science to market while ensuring patients have affordable, timely, and sustainable access to therapy.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Nordic Capital is acquiring the majority stake from Accel-KKR, a global software private equity firm, which first invested in IntegriChain in 2016.
Terms of the transaction, which is expected to complete before the end of the year subject to customary closing conditions, have not been disclosed.
Source: PrivateEquityWire
Can’t stop reading? Read more
Blackstone taps bond market as private credit BDCs end issuance drought
Blackstone taps bond market as private credit BDCs end issuance drought Blackstone's private...
EQT raises the stakes with revised $12.3bn bid for Intertek
EQT raises the stakes with revised $12.3bn bid for Intertek EQT has tabled an improved takeover...
Temasek’s Azalea bets on evergreen structure to democratise private equity access
Temasek's Azalea bets on evergreen structure to democratise private equity access Azalea, a unit...